Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral Livergol on liver enzymes in patients with leukemia
IRCT20150119020715N10Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silybum marianum extract in leukemia, sponsored by Arak University of Medical Sciences. Primary endpoint: Change in liver enzyme levels. Started Jun 2019; status: completed.
02
Drugs
silybum marianum extract
03
Conditions
leukemia
Beyond the preview
Go deeper on IRCT20150119020715N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150119020715N10.